Trump's new tariffs could impact your bank's bottom line -- and your savings. Here's why it might be time to move your money into a high-yield savings account.
Household products company Kimberly-Clark (NYSE:KMB) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 6% year on year to $4.84 billion. Its non-GAAP profit of $1.93 per share was 2% above analysts’ consensus estimates.
Auto and industrial parts retailer Genuine Parts (NYSE:GPC) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.4% year on year to $5.87 billion. Its non-GAAP profit of $1.75 per share was 4.2% above analysts’ consensus estimates.
A $10,000 deposit in a 6-month CD could earn as much as $222.52 at today's rates. Read on to learn more about CDs and see if you should open one today.
Security and aerospace company Northrop Grumman (NYSE:NOC) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 6.6% year on year to $9.47 billion. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $42.25 billion at the midpoint. Its GAAP profit of $3.32 per share was 46.7% below analysts’ consensus estimates.
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 12.1% year on year to $2.65 billion. The company expects the full year’s revenue to be around $10.78 billion, close to analysts’ estimates. Its non-GAAP profit of $2.21 per share was 2.8% above analysts’ consensus estimates.
Credit reporting giant Equifax (NYSE:EFX) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 3.8% year on year to $1.44 billion. Guidance for next quarter’s revenue was better than expected at $1.51 billion at the midpoint, 1.2% above analysts’ estimates. Its non-GAAP profit of $1.53 per share was 9% above analysts’ consensus estimates.
Industrial conglomerate GE Aerospace (NYSE:GE) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $9.00 billion. Its non-GAAP profit of $1.49 per share was 17.3% above analysts’ consensus estimates.
Health insurance provider Elevance Health (NYSE:EVH) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 14.5% year on year to $48.77 billion. Its non-GAAP profit of $11.97 per share was 4.3% above analysts’ consensus estimates.
